Discovery of small molecule VEGFR-2 inhibitors with preferential ocular distribution and retention following oral dosing

被引：0

作者：

Meredith, Erik ^{[1
]}

Mainolfi, Nello ^{[1
]}

Poor, Stephen ^{[1
]}

Qiu, Yubin ^{[1
]}

Miranda, Karl ^{[1
]}

Powers, James ^{[1
]}

Liu, Donglei ^{[1
]}

Ma, Fupeng ^{[1
]}

Solovay, Catherine ^{[1
]}

Rao, Chang ^{[1
]}

Johnson, Leland ^{[1
]}

Ji, Nan ^{[1
]}

Artman, Gerald ^{[1
]}

Hardegger, Leo ^{[1
]}

Hanks, Shawn ^{[1
]}

Shen, Siyuan ^{[1
]}

Woolfenden, Amber ^{[1
]}

Fassbender, Elizabeth ^{[1
]}

Sivak, Jeremy ^{[1
]}

Zhang, Yiqin ^{[1
]}

Long, Debby ^{[1
]}

Cepeda, Rosemarie ^{[1
]}

Hosagrahara, Vinayak ^{[1
]}

Lee, Wendy ^{[1
]}

Tarsa, Peter ^{[1
]}

Liu, Fang ^{[1
]}

Anderson, Karen ^{[1
]}

Newton, Ronald ^{[1
]}

End, Peter ^{[1
]}

Elliott, Jason ^{[1
]}

Jaffee, Bruce ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Cambridge, MA USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

269

引用

页数：1

共 50 条

[31] Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors
Li, Yunqi
Tan, Chunyan
Gao, Chunmei
Zhang, Cunlong
Luan, Xudong
Chen, Xiaowu
Liu, Hongxia
Chen, Yuzong
Jiang, Yuyang
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (15) : 4529 - 4535
[32] Discovery of Anilinopyrimidines as Dual Inhibitors of c-Met and VEGFR-2: Synthesis, SAR, and Cellular Activity
Zhan, Zhengsheng
Ai, Jing
Liu, Qiufeng
Ji, Yinchun
Chen, Tiantian
Xu, Yechun
Geng, Meiyu
Duan, Wenhu
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (06): : 673 - 678
[33] Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-d]pyrimidine
El-Metwally, Souad A.
Elkady, Hazem
Hagras, Mohamed
Elkaeed, Eslam B.
Alsfouk, Bshra A.
Doghish, Ahmed S.
Ibrahim, Ibrahim M.
Taghour, Mohammed S.
Husein, Dalal Z.
Metwaly, Ahmed M.
Eissa, Ibrahim H.
FUTURE MEDICINAL CHEMISTRY, 2023, 15 (22) : 2065 - 2086
[34] Preclinical studies and characterization of BMS-794833, a small molecule inhibitor of Met and VEGFR-2 kinases
Fargnoli, J.
Henley, B. J.
Wautlet, B. S.
Borzilleri, R.
EJC SUPPLEMENTS, 2010, 8 (07): : 41 - 41
[35] Discovery of 1,3-Diaryl-pyridones as Potent VEGFR-2 Inhibitors: Design, Synthesis, and Biological Evaluation
Yan, Wei
Huang, Zhaoru
Wang, Zhengyu
Cao, Sufen
Tong, Linjiang
Zhang, Tao
Wang, Chen
Zhou, Lin
Ding, Jian
Luo, Cheng
Zhou, Jinpei
Xie, Hua
Duan, Wenhu
CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 87 (05) : 694 - 703
[36] Discovery of Novel Potent VEGFR-2 Inhibitors Exerting Significant Antiproliferative Activity against Cancer Cell Lines
Zhang, Yanmin
Chen, Yadong
Zhang, Danfeng
Wang, Lu
Lu, Tao
Jiao, Yu
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (01) : 140 - 157
[37] Discovery of pyridine- sulfonamide hybrids as a new scaffold for the development of potential VEGFR-2 inhibitors and apoptosis inducers
Ahmed, Marwa F.
Santali, Eman Y.
BIOORGANIC CHEMISTRY, 2021, 111
[38] Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2
Shi, Lei
Wu, Ting-Ting
Wang, Zhi
Xue, Jia-Yu
Xu, Yun-Gen
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (17) : 4735 - 4744
[39] Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors: In vitro and in silico studies
Eissa, Ibrahim H.
Elkady, Hazem
Rashed, Mahmoud
Elwan, Alaa
Hagras, Mohamed
Dahab, Mohammed A.
Taghour, Mohammed S.
Ibrahim, Ibrahim M.
Husein, Dalal Z.
Elkaeed, Eslam B.
Al-ghulikah, Hanan A.
Metwaly, Ahmed M.
Mahdy, Hazem A.
HELIYON, 2024, 10 (02)
[40] Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies
Elkaeed, Eslam B.
Yousef, Reda G.
Khalifa, Mohamed M.
Ibrahim, Albaraa
Mehany, Ahmed B. M.
Gobaara, Ibraheem M. M.
Alsfouk, Bshra A.
Eldehna, Wagdy M.
Metwaly, Ahmed M.
Eissa, Ibrahim H.
El-Zahabi, Mohamed Ayman
MOLECULES, 2022, 27 (19):

← 1 2 3 4 5 →